Previous studies have demonstrated that use of blocking IL-7 antibodies or use of IL-7-deficient mice could dramatically decrease human T-ALL formation in xenotransplantation settings using immunocompromised mice27, 42. This evidence concerns the gene IL7 and acute lymphoblastic leukemia.